Offer - Urjas Oil for just ₹ 1 X
Erleva 150 Mg Tablet is a commercial drug that is prescribed in the form of Tablet. It is typically used for the treatment of Pancreatic Cancer, Non-Small Cell Lung Cancer.
Medical history of the patient along with age and gender determines the dosage of Erleva 150 Mg Tablet. Individual symptoms and route of administration also determines the right dosage. Refer to the dosage section for a detailed discussion.
Some other side effects of Erleva 150 Mg Tablet have been listed ahead. Such side effects of Erleva 150 Mg Tablet normally do not last long and go away once the treatment is completed. Consult your doctor if these side effects become worse or stay for a longer duration.
It is also important to note that Erleva 150 Mg Tablet has a Moderate effect for pregnant women and Moderate effect on lactating mothers. Further, the section on Erleva 150 Mg Tablet related warnings talks about Erleva 150 Mg Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Liver Disease, Kidney Disease, Lung Disease must refrain from the use of Erleva 150 Mg Tablet since this can cause severe adverse effects. Other conditions have been mentioned below in the Erleva 150 Mg Tablet contraindications section.
Besides this, Erleva 150 Mg Tablet may also have severe interaction with some medicines. See below for a complete list.
Along with the above-mentioned precautions, remember that taking Erleva 150 Mg Tablet is considered not safe while driving, and is not addictive.
Erleva 150 Mg Tablet is used to treat the following -
Other Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Erleva 150 Mg Tablet safe for pregnant women?
Erleva may have some side effects during pregnancy. Pregnant women should discontinue the use of Erleva, and talk to their doctor, if they notice any discomfort.
Is the use of Erleva 150 Mg Tablet safe during breastfeeding?
Breastfeeding women may feel side effects of Erleva. If you see any side effects, stop taking Erleva immediately and talk to your doctor. Take Erleva again, only after your doctor's advice.
What is the effect of Erleva 150 Mg Tablet on the Kidneys?
Erleva is not harmful for kidneys.
What is the effect of Erleva 150 Mg Tablet on the Liver?
You may experience side effects on your liver after taking Erleva. If this happens, then discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Erleva 150 Mg Tablet on the Heart?
Erleva is completely safe for the heart.
If you are suffering from any of the following diseases, you should not take Erleva 150 Mg Tablet unless your doctor advises you to do so -
Is this Erleva 150 Mg Tablet habit forming or addictive?
No, there is no any evidence that Erleva 150 Mg Tablet is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Erleva 150 Mg Tablet can make you feel drowsy.
Is it safe?
Erleva 150 Mg Tablet should be used only after doctor's advice.
Is it able to treat mental disorders?
No, the use of Erleva 150 Mg Tablet in mental disorders is not effective.
Interaction between Food and Erleva 150 Mg Tablet
Some foods when eaten with Erleva 150 Mg Tablet can alter the onset of actions. Discuss this with your doctor.
Interaction between Alcohol and Erleva 150 Mg Tablet
Information about the interaction of Erleva 150 Mg Tablet and alcohol is not currently available because this topic has not been researched yet.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Tarceva® (erlotinib)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 870
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 514-516